Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression

Multiple sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system (CNS). The immune response in MS patients leads to the infiltration of immune cells in the CNS and their subsequent activation. Immune cell activation induces a switch towards glycolysis. During glycolysis, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wetzels, Suzan, Wouters, Kristiaan, Miyata, Toshio, Scheijen, Jean L. J. M., Hendriks, Jerome J. A., Schalkwijk, Casper G., Vanmierlo, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983766/
https://www.ncbi.nlm.nih.gov/pubmed/29702605
http://dx.doi.org/10.3390/ijms19051311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983766/
https://www.ncbi.nlm.nih.gov/pubmed/29702605
http://dx.doi.org/10.3390/ijms19051311

Ejemplares similares